# FDA Inspection 1181656 - Azenta US, Inc - October 06, 2022

Source: https://www.keypedia.com/records/fda_inspections/azenta-us-inc/8c1cfc37-7ff2-4706-9245-fd29f46b5e81
Source feed: FDA_Inspections

> FDA Inspection 1181656 for Azenta US, Inc on October 06, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181656
- Company Name: Azenta US, Inc
- Inspection Date: 2022-10-06
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1181656 - 2022-10-06](https://www.keypedia.com/records/fda_inspections/azenta-us-inc/841cc2dd-4b20-48c2-abe6-ad6ca5c60557)

Company: https://www.keypedia.com/companies/azenta-us-inc/3dc03a01-747c-4281-956a-3376ec553a2d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d